- Home
- ANTX vs FBIO Comparison
ANTX vs FBIO Comparison
Compare ANTX & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- FBIO
- Stock Information
- Founded
- ANTX 2017
- FBIO 2006
- Country
- ANTX United States
- FBIO United States
- Employees
- ANTX 36
- FBIO N/A
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ANTX Health Care
- FBIO Health Care
- Exchange
- ANTX Nasdaq
- FBIO Nasdaq
- Market Cap
- ANTX 38.5M
- FBIO 44.0M
- IPO Year
- ANTX 2022
- FBIO N/A
- Fundamental
- Price
- ANTX $1.26
- FBIO $1.53
- Analyst Decision
- ANTX Buy
- FBIO Strong Buy
- Analyst Count
- ANTX 4
- FBIO 3
- Target Price
- ANTX $3.50
- FBIO $21.00
- AVG Volume (30 Days)
- ANTX 79.8K
- FBIO 247.1K
- Earning Date
- ANTX 05-13-2025
- FBIO 05-14-2025
- Dividend Yield
- ANTX N/A
- FBIO N/A
- EPS Growth
- ANTX N/A
- FBIO N/A
- EPS
- ANTX N/A
- FBIO N/A
- Revenue
- ANTX N/A
- FBIO $57,675,000.00
- Revenue This Year
- ANTX N/A
- FBIO $63.20
- Revenue Next Year
- ANTX N/A
- FBIO $66.70
- P/E Ratio
- ANTX N/A
- FBIO N/A
- Revenue Growth
- ANTX N/A
- FBIO N/A
- 52 Week Low
- ANTX $0.87
- FBIO $1.33
- 52 Week High
- ANTX $3.07
- FBIO $2.89
- Technical
- Relative Strength Index (RSI)
- ANTX 44.61
- FBIO 46.68
- Support Level
- ANTX $1.18
- FBIO $1.45
- Resistance Level
- ANTX $1.33
- FBIO $1.64
- Average True Range (ATR)
- ANTX 0.09
- FBIO 0.13
- MACD
- ANTX -0.01
- FBIO 0.00
- Stochastic Oscillator
- ANTX 42.86
- FBIO 64.52
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.